Apligraf
Payments companies reported to CMS as associated with Apligraf. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Apligraf, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Apligraf
These are the largest totals companies reported as associated with Apligraf. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Vipul Dev | Bakersfield, CA | Plastic Surgery | $195,186.41 |
| Scott James | Plymouth, MA | Vascular Surgery | $193,200.00 |
| Robert Clemency III | Schererville, IN | Foot & Ankle Surgery | $95,050.62 |
| Amy Tucker | Stow, OH | Orthopaedic Surgery | $92,473.68 |
| Daniel Kapp | West Palm Beach, FL | Plastic Surgery | $90,642.89 |
| George Koullias | East Patchogue, NY | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $68,335.59 |
| Michael Bain | Newport Beach, CA | Plastic Surgery | $65,384.82 |
| Windy Cole | Kent, OH | Foot & Ankle Surgery | $58,550.80 |
| Thomas Zwick | Miami, FL | Foot & Ankle Surgery | $56,587.77 |
| Jeffrey Lehrman | Fort Collins, CO | Foot & Ankle Surgery | $49,929.56 |
Prescribed Apligraf?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.